Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.

Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y.

Int J Cancer. 2008 Mar 1;122(5):1040-6.

2.

Reduced expression of RAS protein activator like-1 in gastric cancer.

Seto M, Ohta M, Ikenoue T, Sugimoto T, Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, Otsuka M, Hirata Y, Maeda S, Koike K, Omata M.

Int J Cancer. 2011 Mar 15;128(6):1293-302. doi: 10.1002/ijc.25459.

3.

Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.

Kumar D, Hassan MK, Pattnaik N, Mohapatra N, Dixit M.

PLoS One. 2017 Oct 26;12(10):e0186977. doi: 10.1371/journal.pone.0186977. eCollection 2017.

4.

Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.

Kim M, Jang HR, Kim JH, Noh SM, Song KS, Cho JS, Jeong HY, Norman JC, Caswell PT, Kang GH, Kim SY, Yoo HS, Kim YS.

Carcinogenesis. 2008 Mar;29(3):629-37. doi: 10.1093/carcin/bgm291. Epub 2008 Feb 17.

PMID:
18283041
5.
6.

Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.

Wanajo A, Sasaki A, Nagasaki H, Shimada S, Otsubo T, Owaki S, Shimizu Y, Eishi Y, Kojima K, Nakajima Y, Kawano T, Yuasa Y, Akiyama Y.

Gastroenterology. 2008 Aug;135(2):580-90. doi: 10.1053/j.gastro.2008.05.041. Epub 2008 May 16.

PMID:
18588891
7.

Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.

Wen XZ, Akiyama Y, Baylin SB, Yuasa Y.

Oncogene. 2006 Apr 27;25(18):2666-73.

PMID:
16314833
8.

IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.

White CD, Khurana H, Gnatenko DV, Li Z, Odze RD, Sacks DB, Schmidt VA.

BMC Gastroenterol. 2010 Oct 26;10:125. doi: 10.1186/1471-230X-10-125.

9.

Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.

Lin YL, Chen HL, Cheng SB, Yeh DC, Huang CC, P'eng FK, Tsai TC, Wu CC, Chen CM.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14257-69. eCollection 2015.

10.

Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.

Gong Y, Guo MZ, Ye ZJ, Zhang XL, Zhao YL, Yang YS.

World J Gastroenterol. 2011 Jan 28;17(4):526-33. doi: 10.3748/wjg.v17.i4.526.

12.

Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.

Hu C, Lin F, Zhu G, Xue X, Ding Y, Zhao Z, Zhang L, Shen X.

Int J Oncol. 2013 Nov;43(5):1487-94. doi: 10.3892/ijo.2013.2078. Epub 2013 Aug 23.

PMID:
23982764
13.

Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.

Ii M, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Ohashi H, Tanuma T, Sukawa Y, Suzuki H, Sasaki S, Imai K, Shinomura Y.

Int J Oncol. 2011 Sep;39(3):593-9. doi: 10.3892/ijo.2011.1048. Epub 2011 May 20.

PMID:
21617852
14.

Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.

Agarwal R, Mori Y, Cheng Y, Jin Z, Olaru AV, Hamilton JP, David S, Selaru FM, Yang J, Abraham JM, Montgomery E, Morin PJ, Meltzer SJ.

PLoS One. 2009 Nov 24;4(11):e8002. doi: 10.1371/journal.pone.0008002.

15.

Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.

Xu X, Chang X, Li Z, Wang J, Deng P, Zhu X, Liu J, Zhang C, Chen S, Dai D.

Cell Oncol (Dordr). 2015 Jun;38(3):183-94. doi: 10.1007/s13402-015-0219-7. Epub 2015 Mar 24.

PMID:
25801783
16.

Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.

Kim M, Lee KT, Jang HR, Kim JH, Noh SM, Song KS, Cho JS, Jeong HY, Kim SY, Yoo HS, Kim YS.

Mol Cancer Res. 2008 Feb;6(2):222-30. doi: 10.1158/1541-7786.MCR-07-0142.

17.

Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.

Chen H, Pan Y, Cheng ZY, Wang Z, Liu Y, Zhao ZJ, Fan H.

Asian Pac J Cancer Prev. 2013;14(11):6261-5.

18.

Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.

Ling Y, Shi X, Wang Y, Ling X, Li Q.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):147-52. doi: 10.1016/j.bbrc.2014.01.012. Epub 2014 Jan 14.

PMID:
24434154
19.

Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.

Chen X, Cao X, Dong W, Xia M, Luo S, Fan Q, Xie J.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):1070-4. doi: 10.1016/j.bbrc.2009.12.022. Epub 2009 Dec 10.

PMID:
20004178
20.

Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.

Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, Go MY, Ng EK, Arakawa T, Chan FK, Sung JJ, Yu J.

J Pathol. 2014 Nov;234(3):302-15. doi: 10.1002/path.4391. Epub 2014 Aug 28.

Supplemental Content

Support Center